by Remy | Jun 12, 2019 | Brain, Fibromyalgia and Pain, Goldstein, Homepage, Nimodipine
Remy provides the second in a series of blogs on using nimidopine – a calcium channel blocking drug – in chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM). As described in Dr. Katherine Downing-Orr’s 2010 book, “Beating Chronic Fatigue Your... 
by Cort Johnson | Jun 6, 2019 | Homepage, Montoya
Through his attorney David Nied of the Astralegal group, Dr. Montoya provided the following statement to Health Rising regarding the events of the past week. Health Rising covered them in this recent post. From David Nied: Following is a statement from my client, Dr.... by Cort Johnson | Jun 4, 2019 | Homepage, Montoya
Eleven years ago, Dr. Jose Montoya bucked his mentor’s advice to stay away from ME/CFS at all costs. In 2008, he made history by opening one of the first chronic fatigue syndrome (ME/CFS) clinic/research centers at a top university. While the promise of his... 
by Cort Johnson | May 29, 2019 | Cervical Stenosis, Cervical Stenosis, Craniocervical Instability, Rowe, Spine, Spine
The Spinal Series This is part three of a series examining spinal issues which may mimic chronic fatigue syndrome (ME/CFS) and fibromyalgia. The first two in the series involved two very ill ME/CFS patients who have recovered or are recovering following surgery to... 
by Cort Johnson | Apr 24, 2019 | Ampligen, Antivirals, Peterson
Dr. Peterson’s been using Ampligen in ME/CFS for 27 years. It seems like the drug has been sitting in limbo regarding ME/CFS forever – yet Ampligen is just one phase 3 trial away from becoming the first FDA-approved drug for ME/CFS – and no other... 
by Cort Johnson | Apr 15, 2019 | Antivirals, Bateman, Energy Production, Gut, Heavy Metals, Homepage, Human Herpes Virus Six (HHV-6), Metabolism, Microbiome, Orthostatic intolerance, Oxidative Stress, Peterson, T-cells
Day two of the Conference – not all of which is covered here, started off with a physicians’ panel, then NIH Director Francis Collins showed up (covered later) just before the Intramural study presented some results, then it was onto Ian Lipkin, Dr. Oh,...
